7. Toxicology Program to Support Initiation of a Clinical Phase I Program for a New Medicine

  1. Mitchell N. Cayen
  1. Hugh E. Black1,
  2. Stephen B. Montgomery2 and
  3. Ronald W. Moch3

Published Online: 3 AUG 2010

DOI: 10.1002/9780470613191.ch7

Early Drug Development

Early Drug Development

How to Cite

Black, H. E., Montgomery, S. B. and Moch, R. W. (2010) Toxicology Program to Support Initiation of a Clinical Phase I Program for a New Medicine, in Early Drug Development (ed M. N. Cayen), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9780470613191.ch7

Editor Information

  1. Cayen Pharmaceutical Consulting, LLC, Bedminster, New Jersey, USA

Author Information

  1. 1

    Hugh E. Black & Associates, Inc., Sparta, New Jersey, USA

  2. 2

    Hugh E. Black & Associates, Inc., Alpharetta, Georgia, USA

  3. 3

    Hugh E. Black & Associates, Inc., Rockville, Maryland, USA

Publication History

  1. Published Online: 3 AUG 2010
  2. Published Print: 23 JUL 2010

ISBN Information

Print ISBN: 9780470170861

Online ISBN: 9780470613191

SEARCH

Options for accessing this content:

  • If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
    http://wiley.force.com/Interface/ContactJournalCustomerServices_V2.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Chapter for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >